Figure 2
Figure 2. Low doses of RG7112 and Peg-IFNα 2a in combination promote MPN CD34+ cell apoptosis. (A) Flow cytometric analysis showing the results of Annexin V staining on normal, PV, and PMF CD34+ cells after 2 days of treatment with 200 nM of RG7112 or 200 ng/mL of Peg-IFNα 2a alone or in combination. (B) Histogram showing the effects of these treatments on the CD34+/AnnexinV+ cell population in normal (n = 5), PV (n = 8), and PMF (n = 6) CD34+ cells after 2 days of treatment with 200 nM of RG7112 or 200 ng/mL of Peg-IFNα 2a alone or in combination. (C) Histogram showing the effects of 4 days of drug treatment on PV CD34+/cleaved caspase-3+ cells (n = 6, P < .05).

Low doses of RG7112 and Peg-IFNα 2a in combination promote MPN CD34+ cell apoptosis. (A) Flow cytometric analysis showing the results of Annexin V staining on normal, PV, and PMF CD34+ cells after 2 days of treatment with 200 nM of RG7112 or 200 ng/mL of Peg-IFNα 2a alone or in combination. (B) Histogram showing the effects of these treatments on the CD34+/AnnexinV+ cell population in normal (n = 5), PV (n = 8), and PMF (n = 6) CD34+ cells after 2 days of treatment with 200 nM of RG7112 or 200 ng/mL of Peg-IFNα 2a alone or in combination. (C) Histogram showing the effects of 4 days of drug treatment on PV CD34+/cleaved caspase-3+ cells (n = 6, P < .05).

Close Modal

or Create an Account

Close Modal
Close Modal